Navigation Links
Deadly Diarrhoea Vaccine – Trail Results Promising

Diarrhoea is a major cause of morbidity and mortality in India. An attempt to formulate// a vaccine against this deadly disease, which has claimed so many young lives, is worth the expense.

India is set to begin the phase II clinical trials of a new vaccine for a deadly form of diarrhoea that causes thousands of deaths annually in India. This move has been accelerated after phase I clinical trials showed up to 70 percent success among adults, children and infants. If the phase II trials are materialized, it is likely to yield more conclusive results towards complete protection from the disease.

The rotaviral diarrhoea contributes 40 percent of the dehydrating diarrhoea disease in infants and young children, causing 150,000 deaths annually in India, which proves that the investment is worthy.

The trial concentrated on the safety and immunogenicity of the two vaccines. The results revealed that the 116E based vaccine is safe and provides up to 70 percent protection with single dose in infants, which may increase to complete protection with two to three doses.

The phase II trial of the 116E vaccine is scheduled to be conducted in New Delhi.

Source:IANS

Medindia on Diarrhoea: Replacement of fluids and electrolytes (salts and minerals) lost due to diarrhoea is the main aim. Self-treatment includes avoiding dehydration by drinking lots of electrolyte solutions that are available in all pharmacies and are dispensed without a prescription.

More on Medindia:

http://www.medindia.net/patients/
PatientInfo/salmonellosis.asp
'"/>




Page: 1

Related medicine news :

1. Smoking and Breast Cancer - A Deadly Combination
2. Latest Findings On The Deadly Disease - SARS
3. Sharp Increase Of The Deadly Diseases In Delhi
4. Imported Plants Could Deadly Harbor Mosquitoes, Says Report
5. Deadly Kiss - Peanut allergy kills a teenager
6. Deadly abortion pill takes two more lives
7. Severe Urinary Infection Could Lead To Deadly Blood Clots
8. Hush…..A Deadly Killer on the Prowl in Rural Andhra Pradesh
9. New Vaccine To Combat The Deadly Marburg Virus
10. Smoking and Obesity- A Deadly Combination
11. Tobacco Deadly In Any Form

Post Your Comments:
(Date:11/27/2009)... manufacturers who use medical load cells at the h...ars by bringing in technology partner Flintec earl...-active medical manufacturers are calling in Flint... projects, ensuring that progress will not be cons...y outdated technology. , ...
(Date:11/26/2009)...thiomolybdate (TM) has been shown in studies to be...isease caused by an overload of copper, and certai...tle, however, is known about how the drug works at...western University researchers now has provided an...of TM bound to copper-loaded metallochaperones. Th...
(Date:11/26/2009)...riangle Dental (RTDental), a leading dental group ...d the expansion of its services to include LUMINEE...llan. , Durham, NC (PR...ounce that Dr. Doug Macmillan, an experienced LUM...advanced training seminar. RTDental’s abili...
(Date:11/25/2009)...v. 25 Onyx Pharmaceuti...he company will host two investor events in Decemb...09 - 9:00 a.m. CT/10:00 a.m. ET ,, Principal ...ounding carfilzomib in relapsed and/or refractory ... Society of Hematology (ASH) Annual Meeting and Ex...
(Date:11/25/2009)...PRNewswire-USNewswire/ -- The Black AIDS Institute...rmine executive leadership for 2010. ,, The new...rs with specialties in public policy, law, finance...ess entrepreneurship. The Board also comes from a ...heterosexual and gay Black men and women, some liv...
Breaking Medicine News(10 mins):Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Black AIDS Institute Announces 2010 Board Election Results 2
...website, http://www.shirleyboard.com, has been re...r Outstanding Achievement in Website Development b... of Excellence WebAward,Designation. ShirleyBOARD...e allows caregivers to centrally store important,i...
...ymour, Iowa, was handed the keys to the E85-powere...f the September 15th Iowa vs. Iowa State,football ...the Ride, Iowa",raffle. The Iowa Farm Bureau donat...r Choice program. The custom designed,motorcycle w...
...pregnancy accelerates progression to full-blown AI...apy. The study, published in the October 1st issue...ilable online, revealed that pregnancy may, in fac...S were told that becoming pregnant would be unwise...
... in the U.S. millions of blood donors see a critic...ain. Of the 14.4 million units of whole blood coll...he four million whole blood-derived platelet conce... no medical requirement or clear need to do so. To...
...asdaq: LMNX ) today announced that management wil...ce to be held September 24-27, 2007, in New,York C...hrop, president and chief,executive officer, and H...nd may be accessed at Luminex,Corporation,s websit...
...: HOLX ) today announced that Glenn Muir, Chief F...bal Life Sciences Conference being held,September ..., NY. Interested parties are invited to listen to...pany,s website at, http://www.hologic.com/investor...
Other Medicine News:Health News:Elder Caregiving Site ShirleyBOARD.com Wins WebAward for Outstanding Online Community 2Health News:Renewable Fuel Chopper Raffle Nets $113,000 for American Lung Association Clean Air Choice Program 2Health News:Pregnancy may slow -- not accelerate -- progression to AIDS 2Health News:Pregnancy may slow -- not accelerate -- progression to AIDS 3Health News:Critical blood shortages eased by new technology 2Health News:Critical blood shortages eased by new technology 3Health News:Luminex Corporation To Present at UBS Global Life Sciences Conference 2
(Date:11/25/2009)...N VIEW, Calif., Nov. 25 ChemoCen...ical data from the Company,s PROTECT-1 (the Prospe...s disease Trial) of Traficet-EN(TM) (CCX282-B) in ...emonstrated clinical efficacy with a favorable saf...ted evidence of clinical efficacy in the reduction...
(Date:11/24/2009)..., Calif., Nov. 24 Endolo... invasive treatments for aortic disorders, announc...scontinue all proceedings in, the patent infringem...Cook, Inc. The motion was filed in the United Sta... Endologix has requested that the stay remain in e...
(Date:11/24/2009)...EGO, Nov. 24 Anadys Phar... that it will present at the 21st Annual Piper Jaf... 2009 at 9:00 a.m. EST (6:00 a.m. PST). The confe... Steve Worland, Ph.D., President and Chief Executi...Anadys and its clinical development programs, ANA5...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2MPA Media Launches New Chiropractic Publication Dynamic Chiropractic PracticeINSIGHTS 55577 1MPA Media Launches New Chiropractic Publication Dynamic Chiropractic PracticeINSIGHTS 55577 2Flu Expert Helps Clear the Confusion About H1N1 Vs Seasonal Flu Vaccination 55574 1Flu Expert Helps Clear the Confusion About H1N1 Vs Seasonal Flu Vaccination 55574 2Gen Probe Begins U S Clinical Study of PROGENSA 28R 29 PCA3 Assay New Molecular Test to Help Assess Prostate Cancer Risk 4910 1Gen Probe Begins U S Clinical Study of PROGENSA 28R 29 PCA3 Assay New Molecular Test to Help Assess Prostate Cancer Risk 4910 2Gen Probe Begins U S Clinical Study of PROGENSA 28R 29 PCA3 Assay New Molecular Test to Help Assess Prostate Cancer Risk 4910 3Gen Probe Begins U S Clinical Study of PROGENSA 28R 29 PCA3 Assay New Molecular Test to Help Assess Prostate Cancer Risk 4910 4
...Inc. (Nasdaq: TRBN ), today announced that Wyeth ...l trial of TRU-015, Trubion,s lead Small,Modular I... the treatment,of non-Hodgkin,s lymphoma (NHL). Th...roup assignment clinical trial is designed to,eval...s with NHL. Trubion,is co-developing TRU-015 and o...
...ith chronic idiopathic,thrombocytopenic purpura in...than or equal to 50,000/microliters with extended ...y,announced data on the long-term safety and effic...ombopag) for the treatment of chronic idiopathic,t...y results from the,EXTEND (Eltrombopag eXTENded Do...
Other Medicine Technology:Trubion Announces Initiation of Phase I/II Clinical Trial of TRU-015 for the Treatment of B-Cell Non-Hodgkin's Lymphoma 2Trubion Announces Initiation of Phase I/II Clinical Trial of TRU-015 for the Treatment of B-Cell Non-Hodgkin's Lymphoma 3Trubion Announces Initiation of Phase I/II Clinical Trial of TRU-015 for the Treatment of B-Cell Non-Hodgkin's Lymphoma 4Long-Term Safety and Efficacy Data on Promacta(TM) (Eltrombopag) Presented at American Society of Hematology Annual Meeting 2Long-Term Safety and Efficacy Data on Promacta(TM) (Eltrombopag) Presented at American Society of Hematology Annual Meeting 3Long-Term Safety and Efficacy Data on Promacta(TM) (Eltrombopag) Presented at American Society of Hematology Annual Meeting 4
...ble, light weight, high power Erbium:YAG laser sys... plastic surgery, general surgery, ENT and ophthal... the smallest, yet among the most powerful, Erbium...eatment for younger patients with mild wrinkles or...
...d to induce interstitial laser coagulation or tiss...en used to induce interstitial laser coagulation, ...rgy to heat the targeted tissue to a temperature r...ow temperatures at which carbonization begins. Whe...
...ghly accurate measurements of intraocular pressure...ic for the diagnosis and treatment of glaucoma. H...-year National Institute of Health (NIH) study pub...ickness (CCT) is an important and necessary biomet...
Gonorrhea Swabs
Medicine Products: